Forum Financial Management, LP Moderna, Inc. Transaction History

Forum Financial Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$101.21 - $166.61 $185,113 - $304,729	1,829 New	1,829 $217,000
Q3 2023 Nov 03, 2023	SELL	$96.41 - $126.61 $964 - $1,266	-10 Reduced 0.42%	2,359 $243,000
Q2 2023 Jul 26, 2023	BUY	$118.5 - $160.53 $48,940 - $66,298	413 Added 21.11%	2,369 $287,000
Q1 2023 Apr 19, 2023	BUY	$135.66 - $197.02 $4,341 - $6,304	32 Added 1.66%	1,956 $300,000
Q4 2022 Jan 24, 2023	BUY	$118.38 - $210.04 $236 - $420	2 Added 0.1%	1,924 $0
Q3 2022 Nov 07, 2022	SELL	$118.07 - $194.18 $80,877 - $133,013	-685 Reduced 26.28%	1,922 $227,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $145,826 - $219,854	1,245 Added 91.41%	2,607 $372,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $5,817 - $10,812	46 Added 3.5%	1,362 $234,000
Q4 2021 Feb 18, 2022	BUY	$225.82 - $368.51 $297,179 - $484,959	1,316 New	1,316 $334,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Forum Financial Management, LP, based on Form 13F filings with the SEC.

Stay updated on Forum Financial Management, LP with notifications on news.